Department of Pediatrics, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92037-0715, USA.
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):627-36. doi: 10.1038/nrgastro.2013.149. Epub 2013 Aug 20.
NAFLD has evolved as a serious public health problem in the USA and around the world. In fact, NASH-the most serious form of NAFLD-is predicted to become the leading cause of liver transplantation in the USA by the year 2020. The pathogenesis of NAFLD and NASH, in particular the mechanisms responsible for liver injury and fibrosis, is the result of a complex interplay between host and environmental factors, and is at the centre of intense investigation. In this Review, we focus on recently uncovered aspects of the genetic, biochemical, immunological and molecular events that are responsible for the development and progression of this highly prevalent and potentially serious disease. These studies bring new insight into this complex disorder and have led to the development of novel therapeutic and diagnostic strategies that might enable a personalized approach in the management of this disease.
非酒精性脂肪性肝病(NAFLD)已成为美国乃至全球的严重公共卫生问题。事实上,预计最严重的非酒精性脂肪性肝病(NASH)形式将成为 2020 年美国肝移植的主要原因。NAFLD 和 NASH 的发病机制,特别是导致肝损伤和纤维化的机制,是宿主和环境因素之间复杂相互作用的结果,也是深入研究的核心。在这篇综述中,我们重点关注最近发现的与这种高度流行且可能严重的疾病的发生和发展有关的遗传、生化、免疫和分子事件的方面。这些研究为这种复杂疾病提供了新的见解,并导致了新的治疗和诊断策略的发展,这可能使这种疾病的管理能够采用个性化方法。